Closet wrote: "The FDA has not seen the data from the S/C trial. NP made that clear in the PR this morning, 'We are very thankful the FDA is allowing severe-to-critical COVID-19 patients access to Vyrologix (leronlimab) again under eIND WHILE WE AWAIT THE UNBLINDING OF DATA from our recently completed Phase 3 registrational trial.'"

I don't think that language tells us the FDA hasn't seen the data. Who is "WE" in NP's sentence? It could be Cytodyn. It could be that the FDA has seen the data, as some (including NP) have said, but Cytodyn has not -- and the latter clause is certainly the case.